celecoxib has been researched along with Anxiety Disorders in 1 studies
Anxiety Disorders: Persistent and disabling ANXIETY.
Excerpt | Relevance | Reference |
---|---|---|
" Cyclo-oxygenase-2 inhibitors such as celecoxib exert anti-inflammatory effects and may enhance the response to antidepressant drug treatment in patients with depressive disorders, but their effect on anxiety symptoms in patients with anxiety disorders is uncertain." | 8.02 | Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study. ( Baldwin, DS; Elnazer, HY; Sampson, AP, 2021) |
" Cyclo-oxygenase-2 inhibitors such as celecoxib exert anti-inflammatory effects and may enhance the response to antidepressant drug treatment in patients with depressive disorders, but their effect on anxiety symptoms in patients with anxiety disorders is uncertain." | 4.02 | Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study. ( Baldwin, DS; Elnazer, HY; Sampson, AP, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Elnazer, HY | 1 |
Sampson, AP | 1 |
Baldwin, DS | 1 |
1 other study available for celecoxib and Anxiety Disorders
Article | Year |
---|---|
Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study.
Topics: Affective Symptoms; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Biomarkers; Celec | 2021 |